SANFORD H. ROTH, M.D.; ALLEN MACKENZIE, M.D.
This content is PDF only. Please click on the PDF icon to access.
The costs of arthritis to society are climbing to an estimated $13.5 billion per year (1). Furthermore, drug development has slowed while the expense of such development has skyrocketed during the last 22 years. In 1962, 46 new drugs—each costing $2 million to research, test, and approve over a mean 2-year development period—were introduced to the market in the United States. In contrast, during 1980, only 17 new drugs were introduced at a mean cost of —70 million per drug, with each drug requiring a 10-year development period. Thus it now costs 35 times as much and takes 5 times
ROTH SH, MACKENZIE A. Drug Development, Guidelines, and the Food and Drug Administration. Ann Intern Med. 1984;101:125–127. doi: https://doi.org/10.7326/0003-4819-101-1-125
Download citation file:
Published: Ann Intern Med. 1984;101(1):125-127.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use